Literature DB >> 14565813

Gender differences in NSAID use among older adults with osteoarthritis.

Kelli L Dominick1, Frank M Ahern, Carol H Gold, Debra A Heller.   

Abstract

BACKGROUND: Nonsteroidal antiinflammatory drugs (NSAIDs) are the most commonly prescribed medications for the treatment of osteoarthritis (OA). Little is known about whether there are important gender differences in NSAID use among patients with OA.
OBJECTIVE: To examine gender differences in patterns of NSAID use among older adults (>or=65 y) with OA.
METHODS: Subjects (n = 11298) were members of a statewide prescription drug plan who responded to a health-related quality-of-life (HRQOL) survey in 1997 and had a physician diagnosis of OA. Gender differences in patterns of NSAID use were examined over a 2-year period.
RESULTS: Approximately one-third of the participants filled at least 1 NSAID prescription during the study. Women were significantly more likely to be prescribed an NSAID than men (37% vs. 30%), had a greater total days' supply of NSAIDs, and were more frequently prescribed NSAIDs with greater degrees of cyclooxygenase-2 selectivity. These gender differences persisted in statistical analyses controlling for demographic factors, HRQOL, and gastrointestinal (GI) risk factors.
CONCLUSIONS: Results of this study showed significant gender differences in patterns of NSAID use, and these differences were independent of the risk for GI adverse effects and self-reported symptoms. Further research is needed to examine reasons for these gender variations, as well as their impact on the quality of symptom management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565813     DOI: 10.1345/aph.1C418

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  8 in total

1.  Diffusion of new medication across different income groups under a universal health insurance program: an example involving newly enlisted nonsteroidal anti-inflammatory drugs for elderly osteoarthritis patients.

Authors:  Pen-Jen Wang; Yiing-Jenq Chou; Cheng-Hua Lee; Christy Pu
Journal:  Int J Public Health       Date:  2010-03-17       Impact factor: 3.380

Review 2.  Sex differences in innate immunity and its impact on opioid pharmacology.

Authors:  Hillary H Doyle; Anne Z Murphy
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

3.  Pattern of NSAID use in the Italian general population: a questionnaire-based survey.

Authors:  Domenico Motola; Alberto Vaccheri; Maria Chiara Silvani; Elisabetta Poluzzi; Ambrogio Bottoni; Fabrizio De Ponti; Nicola Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2004-10-26       Impact factor: 2.953

Review 4.  Sex- and gender-related differences in psoriatic arthritis.

Authors:  Sanjana Tarannum; Ying-Ying Leung; Sindhu R Johnson; Jessica Widdifield; Vibeke Strand; Paula Rochon; Lihi Eder
Journal:  Nat Rev Rheumatol       Date:  2022-08-04       Impact factor: 32.286

5.  How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative.

Authors:  Sarah R Kingsbury; Elizabeth M A Hensor; Ceara A E Walsh; Marc C Hochberg; Philip G Conaghan
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

6.  Assessment of literacy and numeracy skills related to non-steroidal anti-inflammatory drug labels.

Authors:  Soo Min Jang; Ruixin Jiang; Darren Grabe; Amy Barton Pai
Journal:  SAGE Open Med       Date:  2019-03-07

7.  Use of Complementary and Alternative Therapy for Knee Osteoarthritis: Race and Gender Variations.

Authors:  Ernest R Vina; Ada O Youk; Cristian Quinones; C Kent Kwoh; Said A Ibrahim; Leslie R M Hausmann
Journal:  ACR Open Rheumatol       Date:  2021-07-19

8.  Osteoarthritis: quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients.

Authors:  Thomas Rosemann; Gunter Laux; Joachim Szecsenyi
Journal:  J Orthop Surg Res       Date:  2007-06-30       Impact factor: 2.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.